PROMOTION BY THE ALPHA-ADRENOCEPTOR AGONIST PHENYLEPHRINE, BUT NOT BYTHE BETA-ADRENOCEPTOR AGONIST ISOPROTERENOL, OF GASTRIC CARCINOGENESIS INDUCED BY N-METHYL-N'-NITRO-N-NITROSOGUANIDINE IN WISTAR RATS
H. Iishi et al., PROMOTION BY THE ALPHA-ADRENOCEPTOR AGONIST PHENYLEPHRINE, BUT NOT BYTHE BETA-ADRENOCEPTOR AGONIST ISOPROTERENOL, OF GASTRIC CARCINOGENESIS INDUCED BY N-METHYL-N'-NITRO-N-NITROSOGUANIDINE IN WISTAR RATS, Cancer letters, 122(1-2), 1998, pp. 61-65
The effects of prolonged administration of the alpha-adrenoceptor agon
ist phenylephrine and the beta-adrenoceptor agonist isoproterenol on g
astric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine
and on the labeling index of gastric mucosa were compared in Wistar ra
ts. Rats received subcutaneous injections of 3 or 6 mg/kg body weight
of phenylephrine or 0.1 or 0.2 mg/kg body weight of isoproterenol ever
y other day after 25 weeks of oral treatment with the carcinogen. Long
-term administration of phenylephrine at a high dose, but not at a low
dose, significantly increased the incidence of gastric cancers and th
e labeling index of antral epithelial cells at the end of the experime
nt in week 52. However, administration of isoproterenol at either dosa
ge had no significant effect on the incidence of gastric cancers and t
he labeling index of antral epithelial cells. These findings indicate
that increased activity of the sympathetic nervous system enhances gas
tric carcinogenesis through alpha-adrenoceptors. (C) 1998 Elsevier Sci
ence Ireland Ltd.